ICU Medical, Incorporated  

(Public, NASDAQ:ICUI)   Watch this stock  
Find more results for Dianna Finney´┐Ż
113.30
+0.71 (0.63%)
Jul 22 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 111.73 - 113.98
52 week 85.56 - 124.69
Open 112.56
Vol / Avg. 60,304.00/99,599.00
Mkt cap 1.83B
P/E 36.58
Div/yield     -
EPS 3.10
Shares 16.08M
Beta 0.53
Inst. own 91%
Aug 8, 2016
Q2 2016 ICU Medical Inc Earnings Call - 4:30PM EDT - Add to calendar
Aug 8, 2016
Q2 2016 ICU Medical Inc Earnings Release - 4:00PM EDT - Add to calendar
Jun 14, 2016
ICU Medical Inc Annual Shareholders Meeting (Estimated)
May 16, 2016
ICU Medical Inc Annual Shareholders Meeting
May 10, 2016
Q1 2016 ICU Medical Inc Earnings Call - Webcast
May 10, 2016
Q1 2016 ICU Medical Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '16) 2015
Net profit margin 17.70% 13.17%
Operating margin 26.65% 20.07%
EBITD margin - 29.26%
Return on average assets 10.10% 7.70%
Return on average equity 10.85% 8.27%
Employees 2,446 -
CDP Score - -

Address

951 Calle Amanecer
SAN CLEMENTE, CA 92673
United States - Map
+1-949-3662183 (Phone)
+1-949-3668368 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

ICU Medical, Inc. is engaged in the development, manufacturing and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company's product line includes needlefree connection devices, closed system transfer devices (CSTD), needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems. It operates through the segment, which is engaged in the development, manufacturing and sale of medical technologies used in infusion therapy, critical care and oncology applications. Its Infusion Therapy products include MicroClave and MicroClave Clear, Neutron, NanoClave, Clave and SwabCap. Its Critical Care products include Hemodynamic Monitoring Systems, Closed Blood Sampling and Conservation Systems, and Other Critical Care Products and Accessories. Its Oncology products include ChemoLock CSTD and components, ChemoClave CSTD and components and Diana hazardous drug compounding system.

Officers and directors

Vivek Jain Chairman of the Board, Chief Executive Officer
Age: 43
Bio & Compensation  - Reuters
Scott E. Lamb Chief Financial Officer
Age: 53
Bio & Compensation  - Reuters
Steven C. Riggs Vice President - Operations
Age: 57
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Alison D. Burcar Vice President, General Manager - Infusion Systems
Age: 43
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Tom McCall Vice President, General Manager - Critical Care
Age: 58
Bio & Compensation  - Reuters
Elisha W. Finney Director
Age: 54
Bio & Compensation  - Reuters
Joseph R. Saucedo Independent Director
Age: 72
Bio & Compensation  - Reuters
Richard H. Sherman M.D. Independent Director
Age: 68
Bio & Compensation  - Reuters
Robert S. Swinney M.D. Independent Director
Age: 68
Bio & Compensation  - Reuters